Why? Minimal funding is spent on childhood cancer research
Over the past 20 years, only TWO new cancer drug has been approved for pediatric use - Clofarabine (Clolar-Genzyme) in 2004 for ALL and Tenoposide (Vumar/VM-26-BMS) in 1990.
Two Thirds of Childhood Cancer Patients will have long lasting, chronic conditions as a result of the treatment.
So far Liam's only side effect from the chemo is a slight hearing loss
Getting new ear molds made
I wish we could see more research being done to offset these side effects
Like this one which could save the hearing of future hepatoblastoma patients
Other potential side effects Liam may suffer; problems with his heart and problems with his kidneys